Skip to main content

Fomivirsen ophthalmic Pregnancy and Breastfeeding Warnings

Fomivirsen ophthalmic is also known as: Vitravene

Fomivirsen ophthalmic Pregnancy Warnings

Fomivirsen has been assigned to pregnancy category C. There are no controlled data in human pregnancy. Fomivirsen should only be given during pregnancy when benefit outweighs risks.

See references

Fomivirsen ophthalmic Breastfeeding Warnings

There are no data on the excretion of fomivirsen into human milk. Due to the potential for serious adverse effects, a decision should be made to either discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. In addition, HIV-infected mothers should not breast-feed their infants due to the risk of transmission of HIV via breast milk.

See references

References for pregnancy information

  1. "Product Information. Vitravene (fomivirsen ophthalmic)." Apothecon Inc (2022):

References for breastfeeding information

  1. "Product Information. Vitravene (fomivirsen ophthalmic)." Apothecon Inc (2022):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.